Antibody to TIGIT and use thereof

The present invention relates to: an antibody to T cell Immunoreceptor with Ig and Tyrosine-Based Inhibitory Motif Domains (TIGIT), or an antigen-binding fragment thereof; a nucleic acid encoding same; a vector carrying the nucleic acid; a cell transformed with the vector; a method for producing the...

Full description

Saved in:
Bibliographic Details
Main Authors PARK, Hye-Young, NAM, Hye Mi, LEE, Jee Won, LEE, Eun Hee, KIM, Mun Kyung, HUR, Min Kyu, SONG, Eun Jung, SHEEN, Joong Hyuk, LIM, So Jung, WON, Jong Hwa, LIM, Ok Jae, YUM, Hye In, LIM, Yang Mi
Format Patent
LanguageEnglish
Published 04.11.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to: an antibody to T cell Immunoreceptor with Ig and Tyrosine-Based Inhibitory Motif Domains (TIGIT), or an antigen-binding fragment thereof; a nucleic acid encoding same; a vector carrying the nucleic acid; a cell transformed with the vector; a method for producing the antibody or the antigen-binding fragment thereof; and a composition and a composition for combined administration, which comprise same and are for preventing or treating cancer.
Bibliography:Application Number: AU20200290916